Stefan Lutz
CIK 2094828 · Chief Scientific Officer · last filed 2026-02-25
Stefan Lutz is a Chief Scientific Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for CDXS, was dated Feb 25, 2026. Across all open-market trades the lifetime net is −$17.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $193.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$193.7K
1
5
-$17.8K
Filer Profile
200 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | Chief Scientific Officer | 130,421 | $1.49 | $193.7K | -$17.8K | 3 | 2026-02-25 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | CDXS | Mixed | −5,862 | -$6.6K | EDGAR |
| 2026-02-23 | CDXS | Notice (144) | −5,280 | -$6.2K | EDGAR |
| 2026-02-09 | CDXS | Sell (S) | −2,492 | -$3.3K | EDGAR |
| 2026-02-06 | CDXS | Notice (144) | −2,460 | -$3.1K | EDGAR |
| 2026-01-08 | CDXS | Sell (S) | −4,685 | -$7.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.